Global Galidesivir Market Research Report 2024

Publication ID:

PB502250610

Publication Date:

February 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus. In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. Phase 1 clinical trials have begun to determine the safety of this drug in humans. Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.
The global Galidesivir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The approval and regulatory status of Galidesivir in various countries will significantly impact its market trend. Positive clinical trial results and regulatory approvals would open up sales opportunities in those regions. The occurrence and severity of viral outbreaks, such as Ebola or COVID-19, can create a surge in demand for antiviral drugs. The market for Galidesivir may be influenced by the frequency and scale of such outbreaks. The presence of other antiviral drugs in the market, including established ones and those in development, can affect Galidesivir's market share. Competition can lead to price fluctuations and market concentration.
This report aims to provide a comprehensive presentation of the global market for Galidesivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Galidesivir.
Report Scope
The Galidesivir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Galidesivir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Galidesivir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioCryst Pharmaceuticals
ChemScene
Taiclone
CliniSciences
Xi'an Henrikang Biotech Co.
Cayman Chemical
Segment by Type
Galidesivir Powder
Galidesivir Hydrochloride
Segment by Application
Marburg Virus Disease
Filovirus Infections/Ebola Virus Infection
Yellow Fever
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Galidesivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Galidesivir Market Overview
1.1 Product Overview and Scope of Galidesivir
1.2 Galidesivir Segment by Type
1.2.1 Global Galidesivir Market Value Comparison by Type (2024-2030)
1.2.2 Galidesivir Powder
1.2.3 Galidesivir Hydrochloride
1.3 Galidesivir Segment by Application
1.3.1 Global Galidesivir Market Value by Application: (2024-2030)
1.3.2 Marburg Virus Disease
1.3.3 Filovirus Infections/Ebola Virus Infection
1.3.4 Yellow Fever
1.4 Global Galidesivir Market Size Estimates and Forecasts
1.4.1 Global Galidesivir Revenue 2019-2030
1.4.2 Global Galidesivir Sales 2019-2030
1.4.3 Global Galidesivir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Galidesivir Market Competition by Manufacturers
2.1 Global Galidesivir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Galidesivir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Galidesivir Average Price by Manufacturers (2019-2024)
2.4 Global Galidesivir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Galidesivir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Galidesivir, Product Type & Application
2.7 Galidesivir Market Competitive Situation and Trends
2.7.1 Galidesivir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Galidesivir Players Market Share by Revenue
2.7.3 Global Galidesivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Galidesivir Retrospective Market Scenario by Region
3.1 Global Galidesivir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Galidesivir Global Galidesivir Sales by Region: 2019-2030
3.2.1 Global Galidesivir Sales by Region: 2019-2024
3.2.2 Global Galidesivir Sales by Region: 2025-2030
3.3 Global Galidesivir Global Galidesivir Revenue by Region: 2019-2030
3.3.1 Global Galidesivir Revenue by Region: 2019-2024
3.3.2 Global Galidesivir Revenue by Region: 2025-2030
3.4 North America Galidesivir Market Facts & Figures by Country
3.4.1 North America Galidesivir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Galidesivir Sales by Country (2019-2030)
3.4.3 North America Galidesivir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Galidesivir Market Facts & Figures by Country
3.5.1 Europe Galidesivir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Galidesivir Sales by Country (2019-2030)
3.5.3 Europe Galidesivir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Galidesivir Market Facts & Figures by Country
3.6.1 Asia Pacific Galidesivir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Galidesivir Sales by Country (2019-2030)
3.6.3 Asia Pacific Galidesivir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Galidesivir Market Facts & Figures by Country
3.7.1 Latin America Galidesivir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Galidesivir Sales by Country (2019-2030)
3.7.3 Latin America Galidesivir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Galidesivir Market Facts & Figures by Country
3.8.1 Middle East and Africa Galidesivir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Galidesivir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Galidesivir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Galidesivir Sales by Type (2019-2030)
4.1.1 Global Galidesivir Sales by Type (2019-2024)
4.1.2 Global Galidesivir Sales by Type (2025-2030)
4.1.3 Global Galidesivir Sales Market Share by Type (2019-2030)
4.2 Global Galidesivir Revenue by Type (2019-2030)
4.2.1 Global Galidesivir Revenue by Type (2019-2024)
4.2.2 Global Galidesivir Revenue by Type (2025-2030)
4.2.3 Global Galidesivir Revenue Market Share by Type (2019-2030)
4.3 Global Galidesivir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Galidesivir Sales by Application (2019-2030)
5.1.1 Global Galidesivir Sales by Application (2019-2024)
5.1.2 Global Galidesivir Sales by Application (2025-2030)
5.1.3 Global Galidesivir Sales Market Share by Application (2019-2030)
5.2 Global Galidesivir Revenue by Application (2019-2030)
5.2.1 Global Galidesivir Revenue by Application (2019-2024)
5.2.2 Global Galidesivir Revenue by Application (2025-2030)
5.2.3 Global Galidesivir Revenue Market Share by Application (2019-2030)
5.3 Global Galidesivir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BioCryst Pharmaceuticals
6.1.1 BioCryst Pharmaceuticals Corporation Information
6.1.2 BioCryst Pharmaceuticals Description and Business Overview
6.1.3 BioCryst Pharmaceuticals Galidesivir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BioCryst Pharmaceuticals Galidesivir Product Portfolio
6.1.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.2 ChemScene
6.2.1 ChemScene Corporation Information
6.2.2 ChemScene Description and Business Overview
6.2.3 ChemScene Galidesivir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ChemScene Galidesivir Product Portfolio
6.2.5 ChemScene Recent Developments/Updates
6.3 Taiclone
6.3.1 Taiclone Corporation Information
6.3.2 Taiclone Description and Business Overview
6.3.3 Taiclone Galidesivir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taiclone Galidesivir Product Portfolio
6.3.5 Taiclone Recent Developments/Updates
6.4 CliniSciences
6.4.1 CliniSciences Corporation Information
6.4.2 CliniSciences Description and Business Overview
6.4.3 CliniSciences Galidesivir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CliniSciences Galidesivir Product Portfolio
6.4.5 CliniSciences Recent Developments/Updates
6.5 Xi'an Henrikang Biotech Co.
6.5.1 Xi'an Henrikang Biotech Co. Corporation Information
6.5.2 Xi'an Henrikang Biotech Co. Description and Business Overview
6.5.3 Xi'an Henrikang Biotech Co. Galidesivir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio
6.5.5 Xi'an Henrikang Biotech Co. Recent Developments/Updates
6.6 Cayman Chemical
6.6.1 Cayman Chemical Corporation Information
6.6.2 Cayman Chemical Description and Business Overview
6.6.3 Cayman Chemical Galidesivir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cayman Chemical Galidesivir Product Portfolio
6.6.5 Cayman Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Galidesivir Industry Chain Analysis
7.2 Galidesivir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Galidesivir Production Mode & Process
7.4 Galidesivir Sales and Marketing
7.4.1 Galidesivir Sales Channels
7.4.2 Galidesivir Distributors
7.5 Galidesivir Customers
8 Galidesivir Market Dynamics
8.1 Galidesivir Industry Trends
8.2 Galidesivir Market Drivers
8.3 Galidesivir Market Challenges
8.4 Galidesivir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

BioCryst Pharmaceuticals
ChemScene
Taiclone
CliniSciences
Xi'an Henrikang Biotech Co.
Cayman Chemical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂